ReviewCancers2024

Tissue-Agnostic Targeting of Neurotrophic Tyrosine Receptor Kinase Fusions: Current Approvals and Future Directions.

Mohamed A Gouda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.